(I-ACTH) and corticotropin-releasing factor (I-CRF) in the human adrenal was determined and these peptides were indentified in adrenocortical adenomas from patients with primary aldosteronism, Cushing's syndrome, and ovarian tumours and compared with the results in phaeochromocytomas. I-ACTH and I-CRF, mainly localized in the adrenal medulla from patients without endocrine disorders, showed a good correlation with the epinephrine concentrations. I-ACTH and I-CRF were present in all the above-mentioned tumours. Gel filtration of I-ACTH and I-CRF from these tumours showed the presence of large molecular weight forms of these peptides as well as authentic peptides. The trypsinization study of I-CRF from phaeochromocytoma suggested that such large molecular weight forms were the precursors of authentic CRF. High performance liquid chromatography showed I-CRF in these tumours to be similar to hypothalamic CRF. Phaeochromocytoma tissue slices incorporated [3H]leucine into ACTH and CRF. These findings raised the possibility that I-ACTH and I-CRF are synthesized and processed in phaeochromocytoma.
Since the sequence of hypothalamic corticotropinreleasing factor (CRF) was reported (Vale et al. 1981; Shibahara et al. 1983) , the presence of immunoreactive CRF (I-CRF) outside the brain has been demonstrated (Kruseman et al. 1982; Suda et al. 1984a ). In addition, ACTH also exists in extrapituitary tissues (Krieger et (Suda et al. 1984b ). In the present study, we examined the distribution of I-CRF and I-ACTH in the adrenal, and demonstrated the presence of I-ACTH and I-CRF in adrenocortical adenoma and ovarian tumour. In addition, to study the peptide synthesis in phaeochromocy¬ toma, fresh tissue slices were incubated in vitro in medium supplemented with a labelled amino acid and the newly synthesized peptides were analyzed by gel filtration.
Materials and Methods

Homogenization
Adrenal tissues were obtained from 6 patients without endocrine disorders at autopsy between 3 and 6 h post mortem. Phaeochromocytomas (n = 5), adrenal aden¬ omas from patients with primary aldosteronism (n = 5) and Cushing's syndrome (n = (Suda et al. 1980 (Suda et al. , 1984a 
Results
Peptide localization I-CRF and I-ACTH concentrations were higher in the medulla than in the cortex in normal subjects (Table 1 ). In addition, there was a good correlation between the I-ACTH or I-CRF and the epinephrine concentrations (P < 0.01, Fig. 1 ).
I-ACTH and I-CRF concentrations in tumours I-ACTH and I-CRF were detectable in all tum¬ ours as shown in Table 2 . The dilution curves of I-ACTH and I-CRF in all tumours were parallel to those of the standard. I-CRF concentrations in aldosterone-producing adenomas were higher 
HPLC
The elution profile of the fractions comprising the peak of the main component from gel filtra¬ tion of I-CRF in these tumours showed the main peak eluted in the position of synthetic CRF (Fig. 4) . The small peak was also eluted in the position of the sulfoxide form. The elution posi¬ tions of these peaks were identical to those of the human adrenal and hypothalamic extracts.
Vo ACTH 125l
Vo ACTH 125l Fig. 5 ). Rechromatography of I-CRF void volume peak from the control sample (without trypsin) showed a single peak eluted in the void volume. After 30-min incubation with trypsin, three peaks of I-CRF were eluted in the void volume, between the positions of void volume and synthetic CRF ('middle form') and in the position of synthetic CRF. After 60 min, the void volume and 'middle form' peaks of I-CRF decreased, and an I-CRF peak, which might be fragments of I-CRF, appeared after the position of synthetic CRF. The elution profile of I-CRF from gel filtra¬ tion (fractions 26-30 in Fig. 5d) showed the main peak in the position of synthetic CRF on HPLC (Fig. 6 ).
Incorporation of[3H]leucine
Phaeochromocytoma tissue slices incorporated [3H]leucine into peptides during a 2.5-h incuba¬ tion. The level of radioactivity in the affinity column effluent was 10 CPM/ml after the column was washed, and increased significantly when the column was acidified (ACTH: 2500 cpm/5 ml, CRF: 3100 CPM/5 ml). When the samples were applied in the presence of 10 pg of CRF and ACTH, the level of radioactivity in the acidified effluent did not increase. In gel filtration, 3H-labelled ACTH and CRF were eluted in the void volume, between the positions of void vol¬ ume and synthetic peptides, and in those of syn¬ thetic ACTH and CRF (Fig. 7) .
Discussion
The present study showed that I-ACTH and I-CRF were mainly localized in the adrenal me¬ dulla from patients without endocrine disorders and that there was a good correlation between the amounts of these peptides and the epinephrine concentrations. These results agree with previous reports on ACTH, ß-endorphin (Evans et al. 1983) , and other opioid peptides Kakidani et al. 1982; Suda et al. 1983; Lewis et al. 1980) , which are mainly localized in the adrenal medulla. (Suda et al. 1984a,b) , only-a small amount of the sulfoxide form of CRF was ob¬ served; this is due to the addition of ß-mercaptoethanol at each step after homogenization. HPLC elution profiles of I-CRF in fractions in Fig. 5d . The trypsinization and incorporation studies strongly suggest that large molecular weight forms of I-ACTH and I-CRF are precursors of these peptides in phaeochromocytoma. A major peak of I-CRF was eluted in the position of synthetic CRF, and other peaks were not found in the positions of CRF fragments on HPLC after the trypsinization. This may be due to the low cross-reactivity of CRF antiserum with CRF frag¬ ments.
In conclusion, the present study showed I-ACTH and I-CRF to be concentrated in adrenal medulla from patients without endocrine dis¬ orders. In addition, these peptides were present in adrenocortical adenomas and ovarian tumours as well as phaeochromocytomas. The incorpora¬ tion and trypsinization studies strongly suggest the occurrence of synthesis and post-translational processing of I-CRF in phaeochromocytomas. The physiological significance, if any, of the pre¬ sence of I-ACTH and I-CRF in these tissues is unclear.
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